| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Anixa Biosciences, Inc. (ANIX) has 5 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. ANIX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 987.0K | $3.65M | +14.8K | |
| CEO | 640.8K | $2.37M | +10.0K | |
| CFO | 175.0K | $647.5K | - | |
| Dir | 135.0K | $499.5K | - | |
| Dir | 25.0K | $92.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 31, 2016 | Johnson Bruce F | Director | Buy | 2,604 | $3.31 | $8,630.28 | +0.3% | |
| Apr 20, 2016 | Johnson Bruce F | Director | Buy | 500 | $2.88 | $1,438.00 | - | |
| Apr 7, 2016 | Johnson Bruce F | Director | Buy | 200 | $2.82 | $564.00 | - | |
| Mar 31, 2016 | Johnson Bruce F | Director | Buy | 600 | $3.01 | $1,807.00 | - | |
| Mar 28, 2016 | Johnson Bruce F | Director | Buy | 100 | $3.03 | $303.00 | - | |
| Mar 23, 2016 | Johnson Bruce F | Director | Buy | 720 | $2.76 | $1,985.04 | +0.2% | |
| Mar 18, 2016 | Johnson Bruce F | Director | Buy | 500 | $2.85 | $1,425.00 | +0.1% | |
| Mar 14, 2016 | Johnson Bruce F | Director | Buy | 500 | $2.96 | $1,480.00 | +0.1% | |
| Mar 9, 2016 | Johnson Bruce F | Director | Buy | 500 | $2.94 | $1,470.00 | +0.1% | |
| Mar 4, 2016 | Titterton Lewis H Jr65 | Director | Buy | 500 | $3.31 | $1,655.00 | +0.1% |